ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,911Medicare Part D Prescriptions Filled, Including Refills

Rank: 114 out of 670

$686K Total Retail Price of All Prescriptions

Rank: 105 out of 670

453 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 453 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 453 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 8,153 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
LEVOTHYROXINE SODIUM 496 372 1 2
SIMVASTATIN 344 239 2 4
HYDROCHLOROTHIAZIDE 337 287 3 10
HYDROCODONE-ACETAMINOPHEN 330 168 S3 4 1
METOPROLOL TARTRATE 315 242 5 9
OMEPRAZOLE 286 207 6 5
LISINOPRIL 286 206 6 3
AMLODIPINE BESYLATE 279 235 8 7
PRAVASTATIN SODIUM 222 157 9 19
METFORMIN HCL 217 167 10 8
WARFARIN SODIUM 199 179 11 13
NEXIUM 194 132 12 14
SERTRALINE HCL 192 148 13 22
ATORVASTATIN CALCIUM 189 169 14 15
FUROSEMIDE 170 143 15 6
METOPROLOL SUCCINATE 144 108 16 12
CRESTOR 143 115 17 18
PANTOPRAZOLE SODIUM 137 121 18 41
CLOPIDOGREL 133 108 19 24
CITALOPRAM HBR 132 94 20 20
ATENOLOL 126 88 21 17
GABAPENTIN 105 95 22 11
POTASSIUM CHLORIDE 97 86 23 16
ALLOPURINOL 97 66 23 38
GLIMEPIRIDE 92 60 25 32
PLAVIX 90 75 26 34
DIOVAN 85 55 27 48
SYNTHROID 81 79 28 47
ENALAPRIL MALEATE 76 36 29 49
CELEBREX 72 67 30 89
TRAMADOL HCL 71 59 31 21
AZITHROMYCIN 70 57 32 35
DIGOXIN 68 68 33 46
ISOSORBIDE MONONITRATE ER 68 57 33 45
NAMENDA 67 67 35 54
DEXILANT 66 34 36 70
RAMIPRIL 64 55 37 115
MELOXICAM 63 41 38 33
LOSARTAN POTASSIUM 63 63 38 26
NIFEDIPINE ER 62 35 40 145
PAROXETINE HCL 62 45 40 52
PROPRANOLOL HCL 61 44 42 130
PREDNISONE 60 54 43 40
ESCITALOPRAM OXALATE 59 38 44 78
BUPROPION XL 58 0 45 192
TRICOR 57 37 46 83
FLUTICASONE PROPIONATE 57 32 46 37
PREMARIN 56 53 R 48 184
CLONIDINE HCL 55 36 49 62
FLUOXETINE HCL 53 22 50 55
GLYBURIDE 53 34 R 50 85
IBUPROFEN 52 0 52 50
CARBIDOPA-LEVODOPA 51 38 53 101
JANUVIA 51 28 53 53
NIFEDICAL XL 51 38 53 285
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.